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A microfluidic device capable of exploiting the permeability of small molecules through
polydimethylsiloxane (PDMS) has been fabricated in order to control the contents of microdroplets
stored in storage wells. We demonstrate that protein precipitation and crystallization can be triggered
by delivery of ethanol from a reservoir channel, thus controlling the protein solubility in microdroplets.
Likewise quorum sensing in bacteria was triggered by delivery of the auto-inducer N-(3-
oxododecanoyl)-L-homoserine lactone (OdDHL) through the PDMS membrane of the device.
Introduction
Microdroplets in microfluidics are now established as a format
for carrying out chemical and biological experiments at the pico-
to nanolitre scale.1–5 An individual water-in-oil droplet
compartment serves as the equivalent of the conventional test
tube. Droplets can be rapidly produced, processed and interro-
gated for high-throughput experiments while they are moving
through microchannels.6 Alternatively, interrogation of droplet
arrays in which droplets are held static gives high quality data,
allowing even single cell or single molecule measurements.7–10
The droplet boundary can be set-up to prevent transfer processes
(e.g. by diffusion) and cross-contamination can be minimized
through the judicious choice of surfactant, its concentration and
other added components11–13 or by using fluorinated surfactant/
oil systems.8,14–16
Several formats for the addition of reagents to initiate or
terminate a process have been developed. Individual droplets in
a moving droplet stream can be merged or reagent added e.g. by
electrocoalescence,17–20 destabilization of the droplet interface by
surfactant,21–23 or by channel surface patterning.24
The delivery of reagents to static droplet arrays presents
different challenges. It has been shown that static droplets can be
fused by electrocoalescence18,25 or by a laser-induced thermo-
capillary force.26,27 However, these methods require side-by-side
positioning of droplets and the degrees of freedom over the
amount of reagent to be delivered are limited by the proximity of
neighboring droplets.
The work described in this paper demonstrates the ability to
manipulate the contents of droplets based on the permeability of
the PDMS of the device. The compatibility of PDMS with
organic solvents has previously been studied by comparing the
swelling ratio of PDMS in various solvents and their solubil-
ities.28 The ability of hydrophobic small molecules (exemplified
by Nile red and quinine) to permeate PDMS has been
described.29 For example, the permeability of PDMS has been
exploited in the removal of trace organic compounds from an
aqueous sample.30,31 There have also been attempts to reduce the
permeability of PDMS to small molecules by pre-adsorbing
bovine serum albumin (BSA) to the surface,32 by coating the
PDMS with silane33 and by using a large excess of cross-linking
reagents.34 In addition, the adsorption of a hormone onto PDMS
was studied in a microfluidic device.35 We now address the
potential of the permeability of PDMS for initiating multiple
processes in droplets.
In order to utilize the diffusion of small molecules through
PDMS to microdroplets trapped in resting positions, a micro-
fluidic device was built by multilayer soft lithography.36 This
device contained fluid supply channels (reservoir channel) below
the droplets (Fig. S1, ESI†)9,37 from which small molecules can be
supplied for diffusion across the PDMS membrane, and even-
tually transported into the trapped droplets.
In this work two processes that are influenced by small
molecule stimuli were probed, namely protein crystallization and
the control of bacterial gene expression by quorum sensing
molecules. Both processes have been previously addressed in
microdroplets.23,37–41 We now report that ethanol and quorum
sensing molecules can be supplied into droplets in a controlled
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fashion via the permeable PDMS membrane from the reservoir
channel. Delivery of ethanol is shown to trigger protein precipi-
tation and crystallization by addition of a co-solvent that lowers
the protein solubility, thus creating a supersaturated solution
and increasing the crystallization propensity. Delivery of a small
molecule (an auto-inducer of quorum sensing) triggers a cellular
response that is measured indirectly by expression of a reporter
gene encoding a fluorescent protein.
Materials and methods
Device design
The device contains an array of 2000 wells in the storage area
(Fig. S1, ESI†). The droplet deposition is controlled by inlet
valves and occurs via the channels shown in Fig. S1a†. Small
molecules are administered after the wells have been filled with
droplets via a reservoir channel that is separated from the wells
by a thin PDMS membrane (15 mm, Fig. S1b†). Droplets were
stable over 12 hours as assessed by visual inspection.9 No fusion
or break-up of droplets was observed as a result of the addition
of solutes in the reservoir channels.
Device fabrication
The device was drawn with AutoCad (AutoDesk) and photo-
lithographic masks were fabricated on transparent plastics
(Circuit Graphics, Essex, UK). A positive photoresist (AZ-9260,
AZ Electronic Material) was used to build the valve channels42
and negative photoresists (SU8-2025, SU8-2007 Microchem
Inc.) were employed to fabricate the flow channel, wells and
valve-reservoir channel. A commercially available PDMS kit
(Sylgard 184, Dow Corning) composed of a pre-polymer and
a cross-linker was used in the recommended weight ratio of
10 : 1. Two masters were required to fabricate the double-layered
microfluidic device.37 Mixed, degassed liquid PDMS was poured
onto the first master and cured at 75 C for 25 minutes. The
resulting flexible silicone rubber was removed, leaving relief
features from the master imprinted onto the PDMS slab. Injec-
tion holes were punched through the PDMS with lure stub
adapters to insert tubings that deliver the fluid into the device. In
order to fabricate the control channel and the reservoir in the
device, a thin PDMS layer was manufactured onto the face of the
PDMS slab covering them with a glass substrate. This thin layer
was formed by spinning liquid PDMS onto the second master.
The wafer was cured at 85 C for 5 minutes. After alignment and
assembly of the first PDMS slab on the second master, the device
was heated again at 85 C for 30 minutes to enhance adhesion
between two PDMS layers.43 Injection holes were punched to
insert tubing. The resulting PDMS slab was sealed against a glass
slide after plasma treatment.44 CYTOP (Asahi Glass company)
was coated on the flow channels to prevent the water sticking
onto the PDMS walls.
Device operation
Aqueous droplets were formed in fluorinated oil (FC-40,
Fluorinert) previously mixed with surfactants (2% w/w; EA-
surfactant, Raindance Technologies) to prevent the coalescence
of droplets.14 The reservoir constructed underneath the wells
supplied small molecules and organic solvents to droplets
through the PDMS membrane. At the same time the reservoir
maintained the volume of stored droplets from water evapora-
tion of microdroplets. Gene expression in cells was induced at
a constant temperature of 30 C.
Optical detection
Fluorescence images were taken on an inverted microscope
(IX71, Olympus) using a colliminated LED light source
(M455L2-C1, Thorlab) for widefield illumination operated in
epifluorescence mode. In order to monitor large numbers of
arrayed droplets, the device was mounted on a computer-
controlled motorized stage (H117 ProScan II, Prior Scientific)
that moved the device in a pre-determined pattern. To minimize
photobleaching of green fluorescent protein (GFP) produced in
cells, droplets were illuminated only during the acquisition by
means of a computer-controlled LED illumination unit
(M455L2-C1, Thorlab) using the same objective (UPLSAPO
40X2, Olympus). An EMCCD camera (Xion+, Andor Techno-
logies) was used to acquire images, which were saved to the
computer for offline analysis. Automatic acquisitions and image
analysis were performed using softwares written in LabView
(National Instruments). The fluorescence of GFP was measured
from the integration of all green foci above the droplet back-
ground.
Materials
Chemicals were obtained from Sigma-Aldrich unless otherwise
noted.
Protein crystallization
The initial concentration of protein was 59.4 mg ml1 dissolved in
0.2 M sodium chloride, 0.05 M sodium acetate (pH 4.5).
Cell preparation
Escherichia coli (E. coli) cells (DH5a) harboring a pMHLAS
plasmid45 were grown and diluted to an A600nm–0.08, suspended in
LB-media containing ampicillin (30 mg ml1) with 15% v/v of
Percoll and loaded into a syringe (Hamilton, Gastight, 250 ml),
the second identical syringe containing LB-media with various
concentrations of OdDHL. Cells were injected into the micro-
fluidic device in 1 : 1 volume ratio with OdDHL solutions and
emulsified with fluorinated oil (FC-40, Fluorinert) mixed with
EA-surfactant in a flow focusing device (Fig. S1a†).
Results and discussion
Protein crystallization
Protein crystallization is an activated process due to the energy
barrier that prevents crystals below a certain size from growing.46
To grow crystals effectively, it is necessary for protein solutions
to initially be highly supersaturated leading to the formation of
many small crystal nuclei that subsequently grow into large
crystals at lower levels of supersaturation.
In this study a highly supersaturated solution of lysozyme was
achieved by supplying ethanol via the reservoir to droplets































































containing proteins stored in the wells in the microfluidic device.
Fig. 1b–e shows the process of crystal growth in microdroplets.
Initially droplets contained a high concentration of lysozyme,
approximately equivalent to the maximal solubility in water
(59 mg ml1 in 0.2 M sodium chloride, 0.05 M sodium acetate,
pH 4.5) (Fig. 1b and S2a†). When neat ethanol was supplied via
the reservoir channels, the permeability of PDMS28 resulted in an
increase of the ethanol content in the droplet. The solubility of
lysozyme in ethanol is about 300-fold lower (0.2 mg ml1)47 than
it is in aqueous solution,48 so the addition of ethanol reduced the
solubility of the protein and created a supersaturated solution, at
which point the protein precipitated in minutes (Fig. 1c and
S2b†). Such precipitation is frequently observed in highly
supersaturated protein solutions, which is in non-equilibrium
state, and is thought to provide seeds for crystallization.37,49
Although supersaturation is required to nucleate seed crystals,
a subsequent lower degree of supersaturation is necessary for
crystal growth.50 In the next step for protein crystallization, the
reservoir content was changed to water. The ethanol in the
droplets was exchanged via the PDMS for the water supplied
from the reservoir channel, thus lowering the ethanol content in
droplets and dissolving the precipitate over a period of hours
(Fig. 1d and S2c†) to allow crystal growth thereafter. The images
shown in Fig. 1 illustrate this process of transforming many small
crystals into fewer, but larger, crystals over 39 hours (Fig. 1e).51
Some conventional crystallization approaches rely on irre-
versible kinetic processes to partially decouple crystal nucleation
and growth,52 which are difficult to control and optimize.
Microdialysis methods permit independent control of nucleation
and growth53 and this has been implemented in microfluidics.37,54
Our experiments show that protein crystal nucleation and
growth can be independently manipulated by reversibly
controlling the protein solubility in microdroplets.
In order to further demonstrate the control of ethanol content
in droplets, various concentrations of ethanol were introduced
into the reservoir channel and the time until protein precipitation
was measured. For example, precipitation took 20 minutes in
66.7% v/v ethanol in the reservoir channel, but using 100%
ethanol in the reservoir channel decreased the precipitation time
to only 4 minutes (Fig. 1a). As the diffusion coefficient of
ethanol55 in PDMS is 1.7 mm2 s1 and the membrane thickness is
about 15 mm (Fig. S1b, ESI†), we estimate that it takes 2
minutes for ethanol to cross the PDMS membrane based on the
diffusion equation, t ¼ d2/D, where t is the time, d the membrane
thickness and D the diffusion coefficient. Therefore, the differ-
ence in time until precipitation as a function of the ethanol
concentrations can be ascribed to differences in the ethanol flux
crossing the PDMS membrane from reservoir to droplets since
higher concentrations in the reservoir would enhance the ethanol
sorption into the PDMS. It should be noted that ethanol-induced
swelling of the PDMS would reduce the heights of the channels
and this distorted the shape and diameter of the droplets, making
it impossible to quantify the ethanol concentration in the drop-
lets (Fig. 1c and S2b†). No protein precipitation was observed
when concentrations of ethanol in the reservoir were lower than
50% v/v.
Monitoring activation of gene expression by 3-(oxododecanoyl)-
L-homoserine lactone (OdDHL)
The observed permeability of PDMS to ethanol prompted us to
investigate whether small organic signaling molecules might be
delivered to cells entrapped in microdroplets. We used the ability
of cells to respond to auto-inducers (AI) during quorum sensing
(QS). Over the last decade, many species of bacteria have been
shown to respond to self-produced QS signals.56–60
In contrast to QS in vivo, which responds to endogenously
produced AI, in this work the signaling molecule was supplied
exogenously and detected using a genetically reconstituted
version of the las QS system of Pseudomonas aeruginosa
(expressed in a heterologous host, E. coli).45,58,61 Here, exoge-
nously supplied N-(3-oxododecanoyl)-L-homoserine lactone
(OdDHL) was sensed by plasmid-borne LasR, which subse-
quently activated the expression of green fluorescent protein
(GFP) (Fig. 2a).
Fig. 2c shows GFP production in encapsulated cells triggered
by the presence of OdDHL (10 mM) in the reservoir channels,
suggesting OdDHL diffused readily through the PDMS
membrane. In contrast, in the absence of an external trigger, cells
did not produce GFP, showing that the plasmid-based reporter
system used is sufficiently tightly controlled to yield no appre-
ciable GFP expression under these conditions (Fig. S3†).
The total production of GFP in each droplet varied consid-
erably, giving rise to a 20-fold difference in measured
Fig. 1 (a) The time until the precipitation of protein depends on the
concentration of ethanol introduced into the reservoir. The plot shows
the time until protein precipitation could be observed in droplets as
a function of the ethanol content in the reservoir channel. (b) A stable
protein solution of lysozyme stored in wells at the beginning of the
experiment. (c) Precipitation occurred 6 minutes after the reservoir was
filled with 100% ethanol. Ethanol transported from the reservoir to the
droplets, increasing ethanol contents in droplets thereby lowering the
protein solubility. (d and e) After the reservoir channel was filled with
pure water, ethanol continued to evaporate from droplets and was
replaced with water. This increased the solubility of the protein in the
microdroplets and the precipitate dissolved (d) and crystals were subse-
quently formed over 39 hours (e). The size of protein crystals in droplets
varied between 5–30 mm diameter. A time lapse movie shows this process
(see the ESI†).































































fluorescence values around an average of 1.3  104 RFU after
12 hours (Fig. 3a). The significant differences in GFP production
between droplets can be ascribed to different initial cell occu-
pancies in droplets as a consequence of Poissonian encapsulation
of cells8 and the variation in expression levels in individual cells
at a given concentration of auto-inducer.7,9 The latter may be
related to variations in the plasmid copy number in each cell as
well as cell division on the timescale of the experiment.
Concentration dependence of OdDHL delivery
We next examined the OdDHL concentration dependence of
GFP expression in this system. GFP fluorescence was measured
from droplets encapsulating cells in which a range of concen-
trations of OdDHL had been added at the time of droplet
formation (Fig. 3c). The time course of GFP expression showed
the onset to be around one hour after droplet formation. The lag
time between droplet formation and observation of GFP
suggests that time was required for the synthesis and maturation
of the protein fluorophore.62 Fig. 3b shows GFP production as
a function of OdDHL concentration introduced in the reservoir.
When OdDHL was delivered through PDMS, the onset of GFP
fluorescence was delayed slightly more, presumably reflecting the
time required for the OdDHL to diffuse across the membrane
and to accumulate in the droplets. In both cases, GFP produc-
tion increased over the next few hours and displayed saturation,
especially at the higher concentrations of OdDHL tested.63
The magnitude of the GFP signal was strongly dependent on the
OdDHL concentration but reached a maximum when the
concentration was above 0.1 mM (Fig. 4a). Notably, the average
signal intensity at the saturation point was comparable, irre-
spective of the method used to deliver the OdDHL.
As shown in Fig. 4a and b, very few cells produced GFP in the
presence of 0.01 mM of OdDHL; the amount of GFP produced
was 25-fold less than that generated in the presence of 100 mM
OdDHL co-encapsulated with an identical cell preparation. The
amount of GFP increased to a maximum around 1.35  104
RFU at concentrations over 0.1 mM OdDHL. While the final
averaged amount of GFP was independent of the delivery
method employed, the fraction of droplets producing GFP
differed. When OdDHL was directly mixed with cells in droplets
the fraction of droplets producing GFP started to increase at
0.01 mM (only four out of 959 droplets) and saturated around
1 mM (approximately 80% of cell-containing droplets) (squares in
Fig. 4b). By contrast, when the auto-inducer was delivered
through the PDMS membrane, the fraction of droplets
producing GFP slowly started to increase from 0.5% at 0.1 mM to
60% when saturation was reached at 100 mM (circles in Fig. 4b).
This difference can be ascribed to differences in the actual amount
of OdDHL available to cells due to the slow diffusion of OdDHL
from reservoir to droplet, thus limiting GFP expression. The
difference in the fraction of cells expressing GFP (dashed lines in
Fig. 4b) suggests that only1% of the OdDHL introduced in the
reservoir is delivered into the droplet through the membrane.
The reservoir channels constructed under the wells allow the
sequential addition of different molecules to droplets. This can
be used to modulate cellular responses. The initial droplet and
reservoir contents were 100 nM OdDHL and water, respectively.
Around 3.5 hours after droplet formation, the reservoir content
Fig. 2 (a) The chemical structure of OdDHL (N-(3-oxododecanoyl)-L-
homoserine lactone), HHL (N-heptanoyl-L-homoserine lactone) and the
insert in the pMHLAS plasmid encoding the LasR dependent QS
reporter gene.46 (b) A bright-field image of droplets stored in square wells.
The small spots seen in some microdroplets are the fraction of cells that
are in focus. (c) Fluorescence image showing GFP expression at 10 hours
after droplet formation in the presence of 10 mM OdDHL in the reservoir.
The bright spots are cells expressing GFP while encapsulated in micro-
droplets.
Fig. 3 (a) Kinetics of GFP production by E. coli cells encapsulated in
microdroplets in the presence of 10 mM OdDHL in the reservoir. The
graph shows time traces of fluorescence, which were measured at every
20 minutes up to 5 hours and every hour afterwards; the solid line
represents the average. Each symbol corresponds to a droplet containing
cells. In these data, 105 droplets out of 620 showed GFP expression and
were included in the analysis. (b and c) Time course of GFP expression
per droplet at different OdDHL concentrations. OdDHL supplied (b) via
the reservoir or (c) at the time of droplet formation. The dependence of
OdDHL concentrations is similar to experiments using plate reader
detection (Fig. S4†).































































was changed to 10 mM N-heptanoyl-L-homoserine lactone
(HHL) instead of pure water (circle in Fig. 4c). HHL is a quorum
sensing molecule involved in the RaiI/RaiR circuit in Rhizobium
leguminosarum.64,65 Shorter chain homoserine lactones such as
HHL are very weak activators of LasR that compete with
OdDHL and inhibit QS.66–68
Although the bacteria were already ‘switched on’ by OdDHL
that was co-compartmentalized during droplet formation, the
introduction of HHL to the reservoir resulted in a slow down in
GFP production after about 5 hours (Fig. 4c). This suggests that
HHL was delivered to stored droplets from the reservoir and
antagonized the action of OdDHL. The delay between the intro-
duction of HHL and the cellular responses is presumably due to
the slow diffusion process of molecules across the membrane,
which is consistent with the delay time observed in Fig. 3b.
Conclusions
We have shown, using two very different experimental systems,
that delivery of small molecules through PDMS membranes
allows the contents of stored droplets in a microfluidic device to
be manipulated. Small molecules delivered to droplets were
shown to trigger processes as diverse as protein crystallization or
quorum sensing in bacteria.
This approach does not require additional device features for
droplet fusion such as synchronized lasers or electrodes.66
Furthermore, the delivery through PDMS is open to all mole-
cules that are soluble in PDMS. The broad correlation of
calculated log P values and the solubility parameter (Fig. S5†)
can be used to estimate their permeability. A drawback of this
approach is that it is difficult to estimate the concentration of
small molecule that diffuses through the PDMS. This is further
compounded because the ethanol swells the PDMS to make the
channel height unpredictable and the observables in these
experiments were not linearly proportional to the amount of
compound accumulated in droplets. It may be possible to get
some estimate of the concentration of solutes delivered to
droplets by measuring the permeability of fluorescent dye in
PDMS, which has a similar log P value to OdDHL or HHL.
Despite this limitation, the approach clearly has applications in
areas where a threshold concentration is required to trigger
a process or where longer term change in a droplet content is
required.
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